As investment in biomedical research has changed, investigators have become more competitive and focused on work that has a clinical application, Harold Varmus, the outgoing director of the US National Cancer Institute, tells the New York Times. Today is his last day at the agency.
Already have a GenomeWeb or 360Dx account?Login Now.
In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.
Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.
The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.
In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.